| SCHEDULE OF SERIES OF PREFERRED STOCK |
The percentages below are calculated based on 4,500,000
shares of our Series A Preferred Stock issued and outstanding for the fiscal year ending December 31, 2024.
SCHEDULE OF SERIES A PREFERRED STOCK
| Name and Address(1) | |
Title of Class (4) | |
Number of Shares Beneficially Owned | | |
Percent of Class | |
| Mitch Eaglstein | |
Series A Preferred | |
| 500,000 | | |
| 11.11 | % |
| Gope S. Kundnani (5) | |
Series A Preferred | |
| 4,000,000 | | |
| 88.89 | % |
| Officers and Directors as a group (2 persons) | |
Series A Preferred | |
| 4,500,000 | | |
| 100.00 | % |
|
(4) |
Series A Preferred stock is entitled to fifty (50) non-cumulative votes per share on all matters presented to stockholders for action. On December 12, 2016, the Board agreed to issue 2,600,000, 400,000, and 1,000,000 shares of Preferred Stock to Mitchell Eaglstein, Imran Firoz, and Felix R. Hong, respectively, as the founders, in consideration of services rendered to the Company. As of December 31, 2022, the Company had 4,000,000 preferred shares issued and outstanding. |
| |
|
|
|
(5) |
In
January 2023, Eaglstein and Firoz transferred 1,100,000
and 400,000
shares to Gope S. Kundnani, the company’s director. As of September 30, 2023, the Company had 4,000,000
preferred shares issued and outstanding, with Eaglstein, Kundnani, and Hong holding 1,500,000, 1,500,000,
and 1,000,000
shares, respectively. |
|
| SCHEDULE OF SERIES OF PREFERRED STOCK |
The percentages below are calculated based on 2,371,844
shares of our Series B Preferred Stock issued and outstanding for the fiscal year ending March 31, 2025.
SCHEDULE
OF SERIES OF PREFERRED STOCK
| Name and Address(1) | |
Title of Class (6) | |
Number of Shares Beneficially Owned | | |
Percent of Class | |
| Alchemy Prime Holdings Ltd. | |
Series B Preferred | |
| 1,800,000 | | |
| 75.89 | % |
| Gope S. Kundnani | |
Series B Preferred | |
| 191,844 | | |
| 8.09 | % |
| Mitchell M. Eaglstein | |
Series B Preferred | |
| 150,000 | | |
| 6.32 | % |
| Imran Firoz | |
Series B Preferred | |
| 150,000 | | |
| 6.32 | % |
| FRH Group | |
Series B Preferred | |
| 50,000 | | |
| 2.11 | % |
| William B. Barnett | |
Series B Preferred | |
| 10,000 | | |
| 0.42 | % |
| Susan E. Eaglstein | |
Series B Preferred | |
| 10,000 | | |
| 0.42 | % |
| Nick G. Kundnani | |
Series B Preferred | |
| 10,000 | | |
| 0.42 | % |
| Officers and Directors as a group (3 persons) | |
Series B Preferred | |
| 2,291,844 | | |
| 96.63 | % |
|
(6) |
The Series B Preferred Stock is non-dilutive and is not subject to stock splits or any other adjustments to the Company’s common stock. Each share of Series B Preferred Stock can be converted into 100 shares of the Company’s common stock at any time by the holder of such shares. Series B Preferred Stock is entitled to one (1) vote per share on all matters presented to stockholders for action. As a result, 2,361,844 Series B Preferred Stock represents a 0.38% voting percentage on a fully diluted vote per share basis. |
|